How is the heart best protected in chronic dialysis patients?: Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients.
Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Patrick B
PB
Mark
Alison H M
AH
Taylor
Emily P
EP
McQuarrie
Alan G
AG
Jardine
D002318:Cardiovascular Diseases / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D018161:Receptors, Mineralocorticoid / Q000187:drug effects / Q000378:metabolism*; D006435:Renal Dialysis
D000451:Mineralocorticoid Receptor Antagonists; D018161:Receptors, Mineralocorticoid